The potential for citrate to reinforce epigenetic therapy by promoting apoptosis
Trends in Endocrinology & Metabolism · 2023
DOI: 10.1016/j.tem.2023.07.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Endocrinology & Metabolism, 2023. Verfasst von Philippe Icard und 2 weiteren Autor:innen. Beteiligte Einrichtung: Normandie University, UNICAEN, INSERM U1086 Interdisciplinary Research Unit for Cancer Prevention and Treatment, Caen, France; Service de Chirurgie T…. Hauptthemen laut MEDLINE: Citric Acid, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Normandie University, UNICAEN, INSERM U1086 Interdisciplinary Research Unit for Cancer Prevention and Treatment, Caen, France; Service de Chirurgie Thoracique, Hôpital Cochin, Hôpitaux Universitaires Paris Centre, APHP,…
- Service de Chirurgie Thoracique, Hôpital Cochin, Hôpitaux Universitaires Paris Centre, APHP, Université Paris-Descartes, Paris, France; INSERM U1138, Integrative Cancer Immunology, University of Paris, 75006 Paris, Fran…
- Cochin Institute, INSERM U1016, CNRS UMR8104, University of Paris-Cité, Paris, 75014, France.
Zitieren
APA
Icard, P., Alifano, M., & Simula, L. (2023). The potential for citrate to reinforce epigenetic therapy by promoting apoptosis. Trends in Endocrinology & Metabolism. https://doi.org/10.1016/j.tem.2023.07.002
Vancouver
Icard P, Alifano M, Simula L. The potential for citrate to reinforce epigenetic therapy by promoting apoptosis. Trends in Endocrinology & Metabolism. 2023. doi:10.1016/j.tem.2023.07.002
BibTeX
@article{Icard2023,
author = {Icard, Philippe and Alifano, Marco and Simula, Luca},
title = {The potential for citrate to reinforce epigenetic therapy by promoting apoptosis},
journal = {Trends in Endocrinology & Metabolism},
year = {2023},
doi = {10.1016/j.tem.2023.07.002}
}
EUVIMED